Sym004 in Metastatic Colorectal Cancer and ECD-EGFR Patients
收藏NIAID Data Ecosystem2026-03-10 收录
官方服务：
资源简介：
This is a single arm, phase 2, open-label, multicenter trial in patients with metastatic colorectal cancer (mCRC) and acquired resistance to anti-epidermal growth factor receptor (EGFR) monoclonal antibodies (mAbs) and documented mutation of extra cellular domain EGFR (ECD-EGFR).
创建时间：
2016-12-15
